{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:04Z","timestamp":1792686244793,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the relationship between the development of retinopathy of prematurity (ROP) and neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>The medical records of 153 preterm infants born before the 34th week of gestation, were retrospectively reviewed. Complete blood cell (CBC) and C-reactive protein (CRP) results measured within the first 24\u2009h of life were recorded. NLR, LMR and PLR were calculated by dividing neutrophil count by lymphocyte count, lymphocyte count by monocyte count, and platelet count by lymphocyte count, respectively. Analysis of possible risk factors related with ROP development was evaluated using logistic regression analysis. Results were compared between infants with and without ROP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 153 infants, of which 64 (41.9%) with ROP and 89 (58.1%) without ROP, were included in the study. While lymphocyte count and LMR were found to be significantly lower in infants with ROP (<jats:italic>p<\/jats:italic>\u2009=\u20090.015 and <jats:italic>p<\/jats:italic>\u2009=\u20090.044), neutrophil count and NLR were found to be significantly higher (<jats:italic>p<\/jats:italic>\u2009=\u20090.021 and <jats:italic>p<\/jats:italic>\u2009=\u20090.046, respectively). No significant difference were observed in platelet and monocyte count and PLR (<jats:italic>p<\/jats:italic>\u2009=\u20090.808, <jats:italic>p<\/jats:italic>\u2009=\u20090.170 and <jats:italic>p<\/jats:italic>\u2009=\u20090.075, respectively). Multivariate logistic regression analysis revealed that gestational age, birth weight and NLR were major risk factors for the development of ROP (OR:0.59; <jats:italic>p<\/jats:italic>\u2009=\u20090.01, OR:1.00; <jats:italic>p<\/jats:italic>\u2009=\u20090.02 and OR: 2.56; <jats:italic>p<\/jats:italic>\u2009=\u20090.02, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study supports that, in addition to prematurity, NLR on the first postnatal day has a significant predictive value in ROP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41433-024-03260-5","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T14:38:38Z","timestamp":1721918318000},"page":"2822-2826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Predictive value of serum inflammatory markers in retinopathy of prematurity"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-4837","authenticated-orcid":false,"given":"E\u015fay","family":"K\u0131ran Yenice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-547X","authenticated-orcid":false,"given":"Caner","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3563-6622","authenticated-orcid":false,"given":"Tijen","family":"Karsli T\u00fcrkoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-4624","authenticated-orcid":false,"given":"Dilek","family":"Uluba\u015f I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2952-8154","authenticated-orcid":false,"given":"\u0130stemi Han","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"3260_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445\u201357.","journal-title":"Lancet"},{"key":"3260_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/bjophthalmol-2017-310709","volume":"102","author":"JS Mora","year":"2018","unstructured":"Mora JS, Waite C, Gilbert CE, Breidenstein B, Sloper JJ. A worldwide survey of retinopathy prematurity screening. Br J Ophthalmol. 2018;102:9\u201313.","journal-title":"Br J Ophthalmol"},{"key":"3260_CR3","first-page":"327","volume":"19","author":"BE Kurtul","year":"2015","unstructured":"Kurtul BE, Kabatas EU, Zenciroglu A, Ozer PA, Ertugrul GT, Beken S, et al. Serum neutrophil-to-lymphocyte ratio in retinopathy of prematurity. JAAPOS. 2015;19:327\u201331.","journal-title":"JAAPOS"},{"key":"3260_CR4","first-page":"e3","volume":"15","author":"AK Jensen","year":"2011","unstructured":"Jensen AK, Ying GS, Huang J, Karp K, Quinn GE, Binenbaum G. Thrombocytopenia and retinopathy of prematurity. JAAPOS. 2011;15:e3\u2013e4.","journal-title":"JAAPOS"},{"key":"3260_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s12098-013-0986-y","volume":"80","author":"HS Niranjan","year":"2013","unstructured":"Niranjan HS, Bharath Kumar Reddy KR, Benakappa N, Murthy K, Shivananda S, Veeranna V. Role of hematological parameters in predicting retinopathy of prematurity (ROP) in preterm neonates. Indian J Pediatr. 2013;80:726\u201330.","journal-title":"Indian J Pediatr"},{"key":"3260_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1055\/a-1289-0105","volume":"233","author":"K Celik","year":"2021","unstructured":"Celik K, Ekinci D, Asena M, Matur NO. Can hematological parameters be a indicator risk factor in the development of retinopathy of prematurity? Klin Padiatr. 2021;233:216\u201320.","journal-title":"Klin Padiatr"},{"key":"3260_CR7","doi-asserted-by":"publisher","first-page":"8125","DOI":"10.1167\/iovs.13-12496","volume":"54","author":"S Tremblay","year":"2013","unstructured":"Tremblay S, Miloudi K, Chaychi S, Favret S, Binet F, Polosa A, et al. Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Invest Ophthalmol Vis Sci. 2013;54:8125\u201339.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3260_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41372-019-0357-2","volume":"39","author":"GP Goldstein","year":"2019","unstructured":"Goldstein GP, Leonard SA, Kan P, Koo EB, Lee HC, Carmichael SL. Prenatal and postnatal inflammation-related risk factors for retinopathy of prematurity. J Perinatol. 2019;39:964\u201373.","journal-title":"J Perinatol"},{"key":"3260_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.siny.2011.08.007","volume":"17","author":"J Lee","year":"2012","unstructured":"Lee J, Dammann O. Perinatal infection, inflammation, and retinopathy of prematurity. Semin Fetal Neonatal Med. 2012;17:26\u201329.","journal-title":"Semin Fetal Neonatal Med"},{"key":"3260_CR10","first-page":"385","volume":"13","author":"SA Rasoulinejad","year":"2022","unstructured":"Rasoulinejad SA, Maroufi F, Alizadeh A. Clinical parameters in different stages, zones, and remission\/progression statuses of retinopathy of prematurity. Casp J Intern Med. 2022;13:385\u201392.","journal-title":"Casp J Intern Med"},{"key":"3260_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56218-z","volume":"9","author":"R Howard","year":"2019","unstructured":"Howard R, Kanetsky PA, Egan KM. Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep. 2019;9:19673.","journal-title":"Sci Rep"},{"key":"3260_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5543\/tkda.2013.84484","volume":"41","author":"MG Kaya","year":"2013","unstructured":"Kaya MG. Inflammation of coronary artery disease: as a new biomarkers neutrophil\/lymphocyte ratio. Arch Turk Soc Cardiol. 2013;41:191\u20132.","journal-title":"Arch Turk Soc Cardiol"},{"key":"3260_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/hdi.12065","volume":"18","author":"K Turkmen","year":"2014","unstructured":"Turkmen K, Ozcicek F, Ozcicek A, Akbas EM, Erdur FM, Tonbul HZ. The relationship between neutrophil-to-lymphocyte ratio and vascular calcification in end-stage renal disease patients. Hemodial Int. 2014;18:47\u201353.","journal-title":"Hemodial Int"},{"key":"3260_CR14","doi-asserted-by":"publisher","first-page":"e0196706","DOI":"10.1371\/journal.pone.0196706","volume":"13","author":"A Hershko Klement","year":"2018","unstructured":"Hershko Klement A, Hadi E, Asali A, Shavit T, Wiser A, Haikin E, et al. Neutrophils to lymphocytes ratio and platelets to lymphocytes ratio in pregnancy: A population study. PLoS One. 2018;13:e0196706.","journal-title":"PLoS One"},{"key":"3260_CR15","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s10792-021-01756-7","volume":"41","author":"T Ozturk","year":"2021","unstructured":"Ozturk T, Durmaz Engin C, Kaya M, Yaman A. Complete blood count parameters to predict retinopathy of prematurity: when to evaluate and what do they tell us? Int Ophthalmol. 2021;41:2009\u201318.","journal-title":"Int Ophthalmol"},{"key":"3260_CR16","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.4103\/ijo.IJO_2745_20","volume":"69","author":"M Akdogan","year":"2021","unstructured":"Akdogan M, Ustundag Y, Cevik SG, Dogan P, Dogan N. Correlation between systemic immune-inflammation index and routine hemogram-related inflammatory markers in the prognosis of retinopathy of prematurity. Indian J Ophthalmol. 2021;69:2182\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"3260_CR17","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, et al. International classification of retinopathy of prematurity, Third Edition. Ophthalmology. 2021;128:e51\u2013e68.","journal-title":"Ophthalmology"},{"key":"3260_CR18","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233\u201348.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3260_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N. Engl J Med. 2011;364:603\u201315.","journal-title":"N. Engl J Med"},{"key":"3260_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218\u201330.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3260_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.7150\/jca.14206","volume":"7","author":"WK Eo","year":"2016","unstructured":"Eo WK, Kwon S, Koh SB, Kim MJ, Ji YI, Lee JY, et al. The lymphocyte-monocyte ratio predicts patient survival and aggressiveness of endometrial cancer. J Cancer. 2016;7:538\u201345.","journal-title":"J Cancer"},{"key":"3260_CR22","first-page":"1716","volume":"10","author":"YX Hu","year":"2017","unstructured":"Hu YX, Xu XX, Shao Y, Yuan GL, Mei F, Zhou Q, et al. The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity. Int J Ophthalmol. 2017;10:1716\u201321.","journal-title":"Int J Ophthalmol"},{"key":"3260_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/1354750X.2012.656705","volume":"17","author":"HC Kwon","year":"2012","unstructured":"Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, et al. Clinical significance of pre-operative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17:216\u201322.","journal-title":"Biomarkers"},{"key":"3260_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaapos.2017.11.009","volume":"22","author":"AK Jensen","year":"2018","unstructured":"Jensen AK, Ying GS, Huang J, Quinn GE, Binenbaum G. Longitudinal study of the association between thrombocytopenia and retinopathy of prematurity. J AAPOS. 2018;22:119\u201323.","journal-title":"J AAPOS"},{"key":"3260_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000448161","volume":"111","author":"P Lundgren","year":"2017","unstructured":"Lundgren P, Lundberg L, Hellgren G, Holmstr\u00f6m G, H\u00e5rd AL, Smith LE, et al. Aggressive posterior retinopathy of prematurity is associated with multiple infectious episodes and thrombocytopenia. Neonatology. 2017;111:79\u201385.","journal-title":"Neonatology"},{"key":"3260_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4274\/tjo.galenos.2019.45313","volume":"50","author":"A\u0130 Aky\u00fcz \u00dcnsal","year":"2020","unstructured":"Aky\u00fcz \u00dcnsal A\u0130, Key \u00d6, G\u00fcler D, Kurt Omurlu \u0130, An\u0131k A, Demirci B, et al. Can complete blood count parameters predict retinopathy of prematurity? Turk J Ophthalmol. 2020;50:87\u201393.","journal-title":"Turk J Ophthalmol"},{"key":"3260_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12094-011-0687-9","volume":"13","author":"V Asher","year":"2011","unstructured":"Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13:499\u2013503.","journal-title":"Clin Transl Oncol"},{"key":"3260_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","volume":"111","author":"JE Italiano Jr","year":"2008","unstructured":"Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008;111:1227\u201333.","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1038\/s41433-024-03293-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03260-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T07:07:00Z","timestamp":1727334420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03260-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":28,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3260"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03260-5","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41433-024-03293-w","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41433-024-03293-w","URL":"https:\/\/doi.org\/10.1038\/s41433-024-03293-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}